SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the National Kidney Foundation

Citation
Tuttle KR, Brosius FC 3rd, Cavender MA, et al. Am J Kidney Dis 2020; epub ahead of press.